Previous close | 184.70 |
Open | 185.50 |
Bid | 183.70 x 0 |
Ask | 184.10 x 0 |
Day's range | 181.60 - 188.60 |
52-week range | 123.90 - 244.20 |
Volume | |
Avg. volume | 100,766 |
Market cap | 24.922B |
Beta (5Y monthly) | 1.61 |
PE ratio (TTM) | N/A |
EPS (TTM) | -28.33 |
Earnings date | 12 Jul 2024 |
Forward dividend & yield | 1.00 (0.54%) |
Ex-dividend date | 26 Apr 2024 |
1y target est | 228.75 |
Vitrolife AB (publ) has completed the acquisition of eFertility (STB Zorg B.V.) as previously communicated in the press release on 2 May 2024.
Vitrolife AB (publ) today signed an agreement to acquire 100% of the shares in eFertility (STB Zorg B.V.). This acquisition is a key element of the Vitrolife Group's strategy to bring increased standardisation and digitalisation to IVF clinics around the world.
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: